Comment from Insmed Incorporated

Summary: Insmed Incorporated expresses support for the draft guidance on the Plausible Mechanism Framework for developing individualized therapies. They propose specific refinements regarding early engagement with the FDA on observational study designs, natural history characterization, and manufacturing flexibility for small-batch products.